CARs for Hodgkin: engine fine-tuning is in order
Blood Adv
.
2024 Feb 13;8(3):799-801.
doi: 10.1182/bloodadvances.2023012129.
Authors
Natalie S Grover
1
2
,
Carlos A Ramos
3
4
5
Affiliations
1
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
2
Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
3
Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX.
4
Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.
5
Department of Medicine, Section of Hematology and Oncology, Baylor College of Medicine, Houston, TX.
PMID:
38349671
PMCID:
PMC11066405
DOI:
10.1182/bloodadvances.2023012129
No abstract available
Publication types
Editorial
Comment
MeSH terms
Spectrum Analysis, Raman*
T-Lymphocytes*